Authors:
Runnebaum, IB
Wang-Gohrke, S
Vesprini, D
Kreienberg, R
Lynch, H
Moslehi, R
Ghadirian, P
Weber, B
Godwin, AK
Risch, H
Garber, J
Lerman, C
Olopade, OI
Foulkes, WD
Karlan, B
Warner, E
Rosen, B
Rebbeck, T
Tonin, P
Dube, MP
Kieback, DG
Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Authors:
Di Prospero, LS
Seminsky, M
Honeyford, J
Doan, B
Franssen, E
Meschino, W
Chart, P
Warner, E
Citation: Ls. Di Prospero et al., Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey, CAN MED A J, 164(7), 2001, pp. 1005-1009
Authors:
Warner, E
Plewes, DB
Shumak, RS
Catzavelos, GC
Di Prospero, LS
Yaffe, MJ
Goel, V
Ramsay, E
Chart, PL
Cole, DEC
Taylor, GA
Cutrara, M
Samuels, TH
Murphy, JP
Murphy, JM
Narod, SA
Citation: E. Warner et al., Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer, J CL ONCOL, 19(15), 2001, pp. 3524-3531
Citation: Ra. Tabor et al., An oriental weatherfish (Misgurnus anguillicaudatus) population established in Washington state, NW SCI, 75(1), 2001, pp. 72-76
Authors:
Patnaik, A
Warner, E
Michael, M
Egorin, MJ
Moore, MJ
Siu, LL
Fracasso, PM
Rivkin, S
Kerr, I
Litchman, M
Oza, AM
Citation: A. Patnaik et al., Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors, J CL ONCOL, 18(21), 2000, pp. 3677-3689
Authors:
Phillips, KA
Warner, E
Meschino, WS
Hunter, J
Abdolell, M
Glendon, G
Andrulis, IL
Goodwin, PJ
Citation: Ka. Phillips et al., Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2, CLIN GENET, 57(5), 2000, pp. 376-383
Authors:
Liede, A
Cohen, B
Black, DM
Davidson, RH
Renwick, A
Hoodfar, E
Olopade, OI
Micek, M
Anderson, V
De Mey, R
Fordyce, A
Warner, E
Dann, JL
King, MC
Weber, B
Narod, SA
Steel, CM
Citation: A. Liede et al., Evidence of a founder BRCA1 mutation in Scotland, BR J CANC, 82(3), 2000, pp. 705-711
Authors:
Moslehi, R
Chu, W
Karlan, B
Fishman, D
Risch, H
Fields, A
Smotkin, D
Ben-David, Y
Rosenblatt, J
Russo, D
Schwartz, P
Tung, N
Warner, E
Rosen, B
Friedman, J
Brunet, JS
Narod, SA
Citation: R. Moslehi et al., BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer, AM J HU GEN, 66(4), 2000, pp. 1259-1272
Authors:
Warner, E
Foulkes, W
Goodwin, P
Meschino, W
Blondal, J
Paterson, C
Ozcelik, H
Goss, P
Allingham-Hawkins, D
Hamel, N
Di Prospero, L
Contiga, V
Serruya, C
Klein, M
Moslehi, R
Honeyford, J
Liede, A
Glendon, C
Brunet, JS
Narod, S
Citation: E. Warner et al., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer, J NAT CANC, 91(14), 1999, pp. 1241-1247
Authors:
Warner, E
Jensen, JL
Cripps, C
Khoo, KE
Goel, R
Kerr, IA
Bjarnason, GA
Fields, ALA
Hrincu, A
Citation: E. Warner et al., Outpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal carcinoma, ACTA ONCOL, 38(2), 1999, pp. 255-259
Authors:
Warner, E
Heisey, RE
Goel, V
Carroll, JC
McCready, DR
Citation: E. Warner et al., Hereditary breast cancer - Risk assessment of patients with a family history of breast cancer, CAN FAM PHY, 45, 1999, pp. 104-112
Authors:
Foulkes, WD
Brunet, JS
Warner, E
Goodwin, PJ
Meschino, W
Narod, SA
Goss, PE
Glendon, G
Citation: Wd. Foulkes et al., The importance of a family history of breast cancer in predicting the presence of a BRCA mutation, AM J HU GEN, 65(6), 1999, pp. 1776-1779